Ready to invest?
Open a free brokerage account and start building your portfolio today.
Open a free brokerage account and start building your portfolio today.
URGN
$28.00
UroGen is a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options. UroGen has developed RTGel reverse-thermal hydrogel, a proprietary sustained-release, hydrogel-based platform technology that has the potential to improve the therapeutic profiles of existing drugs. UroGen’s sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, mak...
View full profileConnect your bank account to understand your spending habits and explore hypothetical growth scenarios. For educational purposes only — not investment advice.
Educational illustration: hypothetical DCA into UroGen Pharma Ltd (URGN) over the past year. This is not a recommendation to buy this security.
Total Invested
$1,400
14 months
Worth Today
$2,163
at current price
Profit
+$763
+54.5% return
Hypothetical illustration using historical prices. This is for educational purposes only and is not investment advice. Past performance does not guarantee future results. Nuvestan is not a registered investment adviser. Consult a financial professional before making investment decisions.